Previous 10 |
Blue Water Vaccines has exclusive, global licensing rights to Cincinnati Children’s Hospital Medical Center’s novel virus-like particle (VLP) vaccine platform. The data supports BWV’s ongoing development of a transformational universal influenza vaccine, as well...
Blue Water Vaccines (NASDAQ:BWV) shares plunged 50% on Tuesday, hitting a 52-week low, but were still trading 278% above their initial public offering price. Shares of the influenza vaccine developer last changed hands at $34, down 50% from the prior session, at approximately 12:45 p.m. ET. T...
Emerging Markets are outperforming the rest of the world, due in large part to windfall profits in the commodities-exporting countries of South America and the Middle East. If you want to follow the money, this is a good place to start. Money has been flowing out of tech, consumer dis...
CINCINNATI, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing vaccines, today announced the closing of its initial public offering of 2,222,222 shares of its common stock at a public offering ...
Blue Water Vaccines (NASDAQ:BWV) shares tumbled 30% Wednesday as the stock continued to decline after soaring over 500% during its market debut last week. The stock opened at $47.39, falling to $32.55 before shooting up to $51.80 and then sliding into the lower $40 range. Shares of the vaccin...
Larger companies have the advantage of scale, pricing power, greater ability to pass on higher costs to consumers, and stronger negotiating power with suppliers to name a few. Net profit will be an area looked at closely given the potential for multiple Fed rate hikes which will incre...
Newly public Blue Water Vaccines (NASDAQ:BWV) stock was halted several times Tuesday as shares soared 58% early trading before tumbling midday. Shares of the vaccine maker opened at $67.50 after closing at $57.40 on Friday. The stock soared 58% to hit a session high of $90.90 Tuesday morning ...
CINCINNATI, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines, Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing vaccines, today announced the pricing of its initial public offering of 2,222,222 shares of its common stock at a public offering...
News, Short Squeeze, Breakout and More Instantly...
Blue Water Vaccines Inc. Company Name:
BWV Stock Symbol:
NASDAQ Market:
CINCINNATI, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Onconetix, Inc., (Nasdaq: BWV) ("Onconetix" or the “Company”) today issued the following shareholder letter from the Company’s Chief Executive Officer, Dr. Neil Campbell. To Our Valued Shareholders, As 2023 draws to a cl...
CINCINNATI, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Nasdaq: BWV) ("BWB" or the “Company”) today announced the acquisition of Proteomedix AG, a private, commercial-stage diagnostics oncology company (the “Transaction”), and introduced a new name for ...
thyssenkrupp AG (TYEKF) is expected to report for Q4 2023 Azul S.A. American Depositary Shares (each representing three preferred shares) (AZUL) is expected to report $-0.38 for Q3 2023 Bath & Body Works Inc. (BBWI) is expected to report $0.36 for Q3 2024 Johnson Controls Internat...